ASND geopolitical news & exposure

ASND geopolitical news and exposure. ASND appears in 237 Geopolitics Alpha notes. The newest is 24 Sep 2026, 14:14 UTC. Stored price-reaction rows cover 0 of those notes.

• Lilly’s latest China drug deal; Immunovant’s setback in lupus

  24 Sep 2026, 14:14 UTC

• Oppenheimer Initiates Coverage of Pacira BioSciences with Outperform

  24 Sep 2026, 07:36 UTC

• Oppenheimer Initiates Coverage of Amneal Pharmaceuticals at Outperform

  24 Sep 2026, 00:33 UTC

• Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditions

  23 Sep 2026, 19:50 UTC

• Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

  23 Sep 2026, 19:31 UTC

• Roche, Ionis RNA drug scores in kidney disease study

  23 Sep 2026, 16:21 UTC

• 9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe

  23 Sep 2026, 15:13 UTC

• This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval

  23 Sep 2026, 12:58 UTC

• FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow.

  23 Sep 2026, 12:39 UTC

• Oppenheimer Initiates Coverage of Collegium Pharmaceutical with Outperform

  23 Sep 2026, 11:09 UTC

• Amgen reports a Phase 3 win with Sjögren’s drug candidate

  22 Sep 2026, 18:31 UTC

• FDA Accepts Insmed's Filing Seeking Label Expansion for Arikayce

  22 Sep 2026, 16:23 UTC

• Viking shares surge on updated obesity drug data

  22 Sep 2026, 16:10 UTC

• This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

  22 Sep 2026, 15:46 UTC

• Celldex sinks as safety concerns cloud immune drug results

  22 Sep 2026, 15:42 UTC

• Notable ETF Outflow Detected - XBI, TWST, HALO, NTRA

  22 Sep 2026, 15:05 UTC

• An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slide

  22 Sep 2026, 14:17 UTC

• A hidden tradeoff in Trump’s drug pricing deals

  22 Sep 2026, 11:00 UTC

• Cordis wins FDA approval for sirolimus-eluting balloon

  22 Sep 2026, 09:56 UTC

• Novo CEO signals M&A opportunities to strengthen drug pipeline

  22 Sep 2026, 09:00 UTC

• US strikes on alleged drug boats may be ‘crimes against humanity’, UN says

  22 Sep 2026, 03:52 UTC

• Higher rates may not be bad for biotech stocks: find out more

  21 Sep 2026, 21:06 UTC

• Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.

  21 Sep 2026, 19:43 UTC

• Novo talks up drug launches in effort to win back investors

  21 Sep 2026, 16:30 UTC

• Patient Listening Session Summaries

  21 Sep 2026, 13:57 UTC

• FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing

  21 Sep 2026, 12:58 UTC

• Drugs@FDA Data Files

  21 Sep 2026, 12:57 UTC

• FDA Actions to Accelerate and Modernize Early and Late-Stage Clinical Development

  21 Sep 2026, 12:57 UTC

• FDA Roundup: June 18, 2024

  21 Sep 2026, 12:18 UTC

• US strikes on alleged drug boats could be crimes against humanity, says UN

  21 Sep 2026, 12:08 UTC

• Novo Nordisk’s stock tumbles as doubts persist about Ozempic maker’s goals for 2030

  21 Sep 2026, 12:06 UTC

• How J&J paved the way for Compass’ coming psychedelic drug launch

  21 Sep 2026, 11:30 UTC

• Brazil pharmaceutical distributors face mounting financial pressure

  21 Sep 2026, 11:20 UTC

• FDA

  21 Sep 2026, 10:26 UTC

• Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain.

  21 Sep 2026, 10:03 UTC

• Are healthcare systems really ready for GLP-1s?

  21 Sep 2026, 09:00 UTC

• Behind the outcomes: How whole-patient support is reshaping oncology care

  21 Sep 2026, 09:00 UTC

• Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

  21 Sep 2026, 08:58 UTC

• Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

  21 Sep 2026, 04:20 UTC

• Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH Trial

  20 Sep 2026, 01:01 UTC